# PDE4A

## Overview
PDE4A is a gene that encodes the enzyme phosphodiesterase 4A, which is a member of the phosphodiesterase superfamily. This enzyme plays a critical role in cellular signaling by hydrolyzing cyclic adenosine monophosphate (cAMP), a key second messenger involved in various physiological processes. As a phosphodiesterase, PDE4A is responsible for regulating intracellular cAMP levels, thereby modulating cellular responses to external stimuli. The enzyme exists in multiple isoforms, each with distinct regulatory and catalytic domains that influence its function and localization within the cell. These isoforms are involved in compartmentalized cAMP signaling, which is essential for precise cellular signaling and physiological responses (Houslay2001PDE4; Lynch2006Intracellular). PDE4A's interactions with other proteins, such as G-protein-coupled receptors and tyrosyl family kinases, further highlight its role in complex cellular signaling networks (Lynch2006Intracellular). The gene has also been implicated in the pathophysiology of schizophrenia, suggesting its potential clinical significance in neuropsychiatric disorders (Deng2011Positive).

## Structure
The PDE4A gene encodes the phosphodiesterase 4A enzyme, which is involved in the hydrolysis of cyclic AMP (cAMP), a crucial second messenger in cellular signaling. The primary structure of PDE4A consists of a sequence of amino acids that form a conserved catalytic domain shared among the PDE4 subfamilies, including PDE4A, PDE4B, PDE4C, and PDE4D, with 78% of residues being identical across these subfamilies (Wang2007Structures). The secondary structure of PDE4A includes 16 α-helices, contributing to its folding and secondary structure (Wang2007Structures).

The tertiary structure of PDE4A forms a catalytic pocket divided into two sub-pockets for binding bivalent metals and substrates, with zinc and magnesium ions playing crucial roles in catalytic activity (Wang2007Structures). The enzyme also contains regulatory domains, such as upstream conserved regions 1 and 2 (UCR1 and UCR2), which are involved in regulatory phosphorylation by cAMP-dependent protein kinase (PKA) (Day2011Elucidation).

PDE4A has multiple splice variant isoforms, which can affect its function and localization (Day2011Elucidation). The C-terminal regions of PDE4 sub-families are distinct, allowing for subfamily-specific interactions (Houslay2017Identification). These structural features are critical for the enzyme's role in cellular processes and its interaction with various inhibitors.

## Function
PDE4A (phosphodiesterase 4A) is a crucial enzyme in the regulation of intracellular cyclic adenosine monophosphate (cAMP) levels, a key second messenger involved in various cellular signaling pathways. By hydrolyzing cAMP to 5' AMP, PDE4A inactivates this messenger, thereby modulating cellular responses to external stimuli (Lynch2006Intracellular). The enzyme is encoded by the PDE4A gene and exists in multiple isoforms, each with distinct N-terminal regions that determine their specific intracellular localization and function (Houslay2001PDE4).

PDE4A isoforms are involved in compartmentalized cAMP signaling, which is essential for precise cellular signaling and physiological responses. This compartmentalization allows for the differential activation of protein kinase A (PKA) and exchange protein activated by cAMP (EPAC), leading to specific phosphorylation events and cellular outcomes (Lynch2006Intracellular). PDE4A isoforms, such as PDE4A4 and PDE4A5, are activated by various stimuli, including proinflammatory mediators and growth hormone, and are involved in processes like inflammation and cell differentiation (Houslay2001PDE4).

The enzyme's activity is regulated by interactions with other proteins, such as G-protein-coupled receptors and tyrosyl family kinases, which influence its sensitivity to inhibitors and its role in cellular signaling complexes (Lynch2006Intracellular). PDE4A's function in healthy human cells is critical for maintaining cellular homeostasis and responding to environmental changes.

## Clinical Significance
The PDE4A gene has been implicated in the pathophysiology of schizophrenia. Research has shown that certain single nucleotide polymorphisms (SNPs) within PDE4A are associated with schizophrenia in a Japanese population. Specifically, SNP2 of PDE4A demonstrated a significant association with schizophrenia in a replication sample set, suggesting a potential genetic link to the disorder (Deng2011Positive). The study highlights the gene's potential involvement in schizophrenia through genetic association, although it does not provide direct evidence of clinical significance from PDE4A gene mutations or expression alterations (Deng2011Positive).

PDE4A is also part of the phosphodiesterase superfamily, which regulates signal transduction. It has been reported to interact with disrupted-in-schizophrenia 1 (DISC1), a known risk factor for schizophrenia, suggesting that alterations in PDE4A expression or interactions may contribute to the disorder (Deng2011Positive). The study supports the glutamatergic dysfunction hypothesis of schizophrenia, indicating that disruptions in glutamate neurotransmission, potentially involving PDE4A, contribute to the disease (Deng2011Positive). These findings underscore the potential clinical significance of PDE4A in understanding the genetic basis of schizophrenia and its interaction with neurotransmitter systems.

## Interactions
PDE4A, specifically the PDE4A5 isoform, interacts with the immunophilin XAP2. This interaction is mediated through the tetratricopeptide repeat (TPR) domain of XAP2 and the EELD motif in the upstream conserved region 2 (UCR2) of PDE4A5. The binding of XAP2 to PDE4A5 results in a marked inhibition of PDE4A5 activity and increases its sensitivity to the PDE4-selective inhibitor rolipram. This suggests that XAP2 may alter the conformation of PDE4A5, affecting its rolipram sensitivity (Bolger2003Attenuation).

PDE4A5 also interacts with the SH3 domains of Src family tyrosyl kinases, such as Lyn and Fyn, through its N-terminal splice region. This interaction is specific to certain splice variants like RPDE-6, which contains proline/arginine-rich regions that facilitate binding to SH3 domains. However, this binding does not significantly alter the phosphodiesterase activity of PDE4A5 (O’CONNELL1996The).

These interactions highlight the role of PDE4A in cellular signaling, where it is modulated by various proteins, influencing its activity and localization within the cell (Houslay1997Intracellular).


## References


[1. (O’CONNELL1996The) Jonathan C. O’CONNELL, J. Fraser McCALLUM, Ian McPHEE, Jill WAKEFIELD, Emma S HOUSLAY, William WISHART, Graeme BOLGER, Margaret FRAME, and Miles D. HOUSLAY. The sh3 domain of src tyrosyl protein kinase interacts with the n-terminal splice region of the pde4a camp-specific phosphodiesterase rpde-6 (rnpde4a5). Biochemical Journal, 318(1):255–261, August 1996. URL: http://dx.doi.org/10.1042/bj3180255, doi:10.1042/bj3180255. This article has 81 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj3180255)

[2. (Houslay2017Identification) Kirsty F. Houslay, Frank Christian, Ruth MacLeod, David R. Adams, Miles D. Houslay, and George S. Baillie. Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (pde4) that is utilised by multiple interaction partners. Biochemical Journal, 474(4):597–609, February 2017. URL: http://dx.doi.org/10.1042/bcj20160849, doi:10.1042/bcj20160849. This article has 28 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bcj20160849)

[3. (Day2011Elucidation) Jonathan P. Day, Barbara Lindsay, Tracy Riddell, Zhong Jiang, Robert W. Allcock, Achamma Abraham, Sebastian Sookup, Frank Christian, Jana Bogum, Elisabeth K. Martin, Robert L. Rae, Diana Anthony, Georgina M. Rosair, Daniel M. Houslay, Elaine Huston, George S. Baillie, Enno Klussmann, Miles D. Houslay, and David R. Adams. Elucidation of a structural basis for the inhibitor-driven, p62 (sqstm1)-dependent intracellular redistribution of camp phosphodiesterase-4a4 (pde4a4). Journal of Medicinal Chemistry, 54(9):3331–3347, April 2011. URL: http://dx.doi.org/10.1021/jm200070e, doi:10.1021/jm200070e. This article has 33 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1021/jm200070e)

[4. (Deng2011Positive) Xiangdong Deng, Hiromi Takaki, Lixiang Wang, Tosihide Kuroki, Tatsuo Nakahara, Kijiro Hashimoto, Hideaki Ninomiya, Tadao Arinami, Toshiya Inada, Hiroshi Ujike, Masanari Itokawa, Mamoru Tochigi, Yuichiro Watanabe, Toshiyuki Someya, Hiroshi Kunugi, Nakao Iwata, Norio Ozaki, Hiroki Shibata, and Yasuyuki Fukumaki. Positive association of phencyclidine‐responsive genes, pde4a and plat, with schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 156(7):850–858, August 2011. URL: http://dx.doi.org/10.1002/ajmg.b.31233, doi:10.1002/ajmg.b.31233. This article has 16 citations.](https://doi.org/10.1002/ajmg.b.31233)

[5. (Wang2007Structures) Huanchen Wang, Ming-Sheng Peng, Yi Chen, Jie Geng, Howard Robinson, Miles D. Houslay, Jiwen Cai, and Hengming Ke. Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors. Biochemical Journal, 408(2):193–201, November 2007. URL: http://dx.doi.org/10.1042/bj20070970, doi:10.1042/bj20070970. This article has 94 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20070970)

[6. (Lynch2006Intracellular) Martin J. Lynch, Elaine V. Hill, and Miles D. Houslay. Intracellular Targeting of Phosphodiesterase‐4 Underpins Compartmentalized cAMP Signaling, pages 225–259. Elsevier, 2006. URL: http://dx.doi.org/10.1016/S0070-2153(06)75007-4, doi:10.1016/s0070-2153(06)75007-4. This article has 56 citations.](https://doi.org/10.1016/S0070-2153(06)75007-4)

[7. (Houslay2001PDE4) Miles D Houslay. PDE4 cAMP-specific phosphodiesterases, pages 249–315. Elsevier, 2001. URL: http://dx.doi.org/10.1016/s0079-6603(01)69049-4, doi:10.1016/s0079-6603(01)69049-4. This article has 194 citations.](https://doi.org/10.1016/s0079-6603(01)69049-4)

[8. (Bolger2003Attenuation) Graeme B. Bolger, Alexander H. Peden, Michael R. Steele, Carolynn MacKenzie, David G. McEwan, Derek A. Wallace, Elaine Huston, George S. Baillie, and Miles D. Houslay. Attenuation of the activity of the camp-specific phosphodiesterase pde4a5 by interaction with the immunophilin xap2. Journal of Biological Chemistry, 278(35):33351–33363, August 2003. URL: http://dx.doi.org/10.1074/jbc.M303269200, doi:10.1074/jbc.m303269200. This article has 196 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M303269200)

[9. (Houslay1997Intracellular) M. D. Houslay, G. Scotland, S. Erdogan, E. Huston, S. Mackenzie, J. F. McCallum, I. McPhee, L. Pooley, G. Rena, A. Ross, M. Beard, A. Peder, F. Begg, I. Wilkinson, S. Yarwood, C. Ackerman, E. S. Houslay, R. Hoffman, P. Engels, M. Sullivan, and G. Bolger. Intracellular targeting, interaction with src homology 3 (sh3) domains and rolipram-detected conformational switches in camp-specific pde4a phosphodiesterase. Biochemical Society Transactions, 25(2):374–381, May 1997. URL: http://dx.doi.org/10.1042/bst0250374, doi:10.1042/bst0250374. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/bst0250374)